Related Experiment Video
Updated: Jun 1, 2026
Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart
Published on: January 7, 2019
Stem cell therapy for heart diseases
Abdul M Mozid1, Samer Arnous, Eva C Sammut
1Department of Cardiology, The London Chest Hospital, UK.
Insights
The human heart can regenerate, prompting research into stem cell therapy for cardiovascular repair. Further collaboration is needed to optimize cell types and delivery for maximum patient benefit in heart failure and myocardial infarction.
Area of Science:
- Regenerative Medicine
- Cardiology
- Stem Cell Therapy
Background:
- Cardiovascular disease (CVD) is a leading global cause of death.
- High mortality rates persist for acute myocardial infarction (1-year: 13%) and heart failure (5-year: 50%).
- Loss of cardiomyocytes, previously deemed irreversible, contributes to left ventricular systolic dysfunction and poor prognosis.
Purpose of the Study:
- To review current evidence on cardiac repair and stem cell therapy.
- To explore the potential of regenerative approaches for myocardial restoration.
Main Methods:
- Comprehensive literature review of peer-reviewed journals.
- Analysis of data from ClinicalTrials.gov.
Main Results:
- Growing evidence suggests the human heart possesses regenerative capabilities.
- Stem cell research is increasing, aiming to restore myocardial function.
- The exact mechanisms of cell therapy for cardiac repair and its translation to humans require further investigation.
Conclusions:
- Clinical trials for stem cell therapy in acute myocardial infarction and chronic heart failure are expanding.
- Understanding optimal cell types and delivery methods is crucial for maximizing therapeutic benefits.
- Enhanced collaboration between scientists and clinicians is essential for advancing cardiac regenerative medicine.
Background:
Cardiovascular disease is the leading cause of morbidity and mortality worldwide. Despite the advances in medical and catheter-based therapy for acute myocardial infarction the 1-year mortality remains as high as 13% and the 5-year prognosis for patients with heart failure remains as high as 50%. Left ventricular systolic dysfunction, a major determinant of prognosis, is associated with significant loss of cardiomyocytes which was previously thought to be irreversible as the heart was considered a post-mitotic organ.
Sources Of Data:
Review of literature published in peer reviewed journals and ClinicalTrials.Gov website.
Areas Of Agreement:
There is now growing evidence that the human heart is capable of undergoing repair and in recent years there has been an increase in basic and clinical research with the aim of harnessing the regenerative properties of stem cells in order to facilitate restoration of myocardial function.
Areas Of Controversy:
The mechanisms of action of cell therapy with regards to cardiac repair remain unsatisfactorily understood and the magnitude of benefit demonstrated in animal models is yet to be fully translated in humans.
Growing Points:
The number of clinical trials continues to increase and include treating patients with acute myocardial infarction and chronic heart failure secondary to ischaemic heart disease or dilated cardiomyopathy.
Areas Timely For Developing Research:
The future of this field of research will require closer collaboration between scientists and clinicians to understand how cell therapy works and to define the ideal cell type and method of delivery to be able to derive maximum benefit.
Related Concept Videos
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:17Stem Cell Culture
01:22iPS Cell Differentiation
00:57Embryonic Stem Cells
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
00:58Embryonic Stem Cells